These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2056055)

  • 21. Seroprevalence of anti-HTLV I/II and anti-HIV-1 antibodies in a sample population in the Marche Region, Italy.
    Mignini F; Quarenghi L; Cipriani S; Bartolucci M; Covelli I
    Eur J Epidemiol; 1994 Dec; 10(6):769-71. PubMed ID: 7672061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans.
    Wiktor SZ; Cannon RO; Atkinson WL; Lutz B; Hook EW; Blattner WA; Quinn TC
    J Infect Dis; 1992 May; 165(5):920-4. PubMed ID: 1569344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II.
    Roberts BD; Foung SK; Lipka JJ; Kaplan JE; Hadlock KG; Reyes GR; Chan L; Heneine W; Khabbaz RF
    J Clin Microbiol; 1993 Feb; 31(2):260-4. PubMed ID: 8432811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and differentiation of antibodies to human T-cell lymphotropic virus types I and II by the immunofluorescence method.
    Gallo D; Penning LM; Hanson CV
    J Clin Microbiol; 1991 Oct; 29(10):2345-7. PubMed ID: 1939596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of surrogate markers for human immunodeficiency virus infection among blood donors at the blood bank of "Hospital Universitário Regional Norte do Paraná", Londrina, PR, Brazil.
    Reiche EM; Vogler IH; Morimoto HK; Bortoliero AL; Matsuo T; Yuahasi KK; Cancian SJ; Koguichi RS
    Rev Inst Med Trop Sao Paulo; 2003; 45(1):23-7. PubMed ID: 12751318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
    Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
    Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence of human T cell leukemia viruses in selected populations of homosexual men.
    Meyer RD; Moudgil T; Detels R; Phair JP; Hirsch MS; Ho DD
    J Infect Dis; 1990 Dec; 162(6):1370-2. PubMed ID: 2230268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of Liaison XL automated immunoassay platform for blood-borne infection screening on hepatitis B, hepatitis C, HIV 1/2, HTLV 1/2 and Treponema pallidum serological markers.
    Malm K; Kragsbjerg E; Andersson S
    Transfus Med; 2015 Apr; 25(2):101-5. PubMed ID: 25779614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low prevalence of human T lymphotropic virus type I in !Kung San in Bushmanland, Namibia.
    Steele AD; Bos P; Joubert JJ; Evans AC; Joseph S; Tucker L; Aspinall S; Lecatsas G
    Am J Trop Med Hyg; 1994 Oct; 51(4):460-5. PubMed ID: 7943573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study.
    Busch MP; Laycock M; Kleinman SH; Wages JW; Calabro M; Kaplan JE; Khabbaz RF; Hollingsworth CG
    Blood; 1994 Feb; 83(4):1143-8. PubMed ID: 8111054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selectivity of human T lymphotropic virus type-1 (HTLV-1) and HTLV-2 infection among different populations in Brazil.
    Gabbai AA; Bordin JO; Vieira-Filho JP; Kuroda A; Oliveira AS; Cruz MV; Ribeiro AA; Delaney SR; Henrard DR; Rosario J
    Am J Trop Med Hyg; 1993 Dec; 49(6):664-71. PubMed ID: 8279633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Western immunoblot antigens and interpretive criteria for detection of antibody to human T-lymphotropic virus types I and II.
    Gallo D; Diggs JL; Hanson CV
    J Clin Microbiol; 1990 Sep; 28(9):2045-50. PubMed ID: 1977764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies for diagnosis of HTLV-I and -II.
    Thorstensson R; Albert J; Andersson S
    Transfusion; 2002 Jun; 42(6):780-91. PubMed ID: 12147033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked western immunoblot for serological confirmation of human T-cell lymphotropic virus type I and type II infections.
    Lal RB; Brodine S; Kazura J; Mbidde-Katonga E; Yanagihara R; Roberts C
    J Clin Microbiol; 1992 Feb; 30(2):296-9. PubMed ID: 1347047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens.
    Tosswill JH; McAlpine L; Mortimer PP
    J Med Virol; 1993 May; 40(1):83-5. PubMed ID: 8099946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human T-cell lymphotropic virus type I and II seroprevalence among volunteer blood donors in Thailand.
    Oota S; Chaiwong K; Pikulsod S; Khuenkaew R; Pheakkhuntod S; Rattajak P; Kramkratok P; Shiu C; Bhatnagar S; Sakuldamrongpanich T
    Pathog Glob Health; 2018 Oct; 112(7):343-348. PubMed ID: 30424716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of evidence for human T cell lymphotrophic virus type I or II infection in patients with systemic lupus erythematosus or rheumatoid arthritis.
    Bailer RT; Lazo A; Harisdangkul V; Ehrlich GD; Gray LS; Whisler RL; Blakeslee JR
    J Rheumatol; 1994 Dec; 21(12):2217-24. PubMed ID: 7535355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.
    Bonis J; Baillou A; Barin F; Verdier M; Janvier B; Denis F
    J Clin Microbiol; 1993 Jun; 31(6):1481-5. PubMed ID: 8314990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of human T cell lymphotropic virus types 1 and 2 (HTLV-1/2) in selected Tijuana subpopulations.
    Guerena-Burgueno F; Benenson AS; Sepulveda-Amor J; Ascher MS; Vugia DJ; Gallo D
    Am J Trop Med Hyg; 1992 Aug; 47(2):127-32. PubMed ID: 1503181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of four commercial screening assays for the diagnosis of human T-cell lymphotropic virus types 1 and 2.
    Berini CA; Susana Pascuccio M; Bautista CT; Gendler SA; Eirin ME; Rodriguez C; Pando MA; Biglione MM
    J Virol Methods; 2008 Feb; 147(2):322-7. PubMed ID: 17977605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.